Orally disintegrating solid pharmaceutical dosage unit containing a partus control substance
AssigneeOxytone Bioscience B.V.
InventorsJohannes Jan PLATTEEUW, Herman Jan Tijmen COELINGH BENNINK
Life of this patent
Estimating the term…
Loading patent…
AssigneeOxytone Bioscience B.V.
InventorsJohannes Jan PLATTEEUW, Herman Jan Tijmen COELINGH BENNINK
Estimating the term…
The present invention provides an orally disintegrating solid pharmaceutical dosage unit having a weight between 50 and 1,000 mg, said dosage unit consisting of: 1-100 wt. % of particles consisting of: 0.01-10 wt. % of a partus control substance selected from oxytocin, carbetocin, atosiban and combinations thereof; 5-70 wt. % of buffering agent; 20-94 wt. % of branched glucan; 0-70 wt. % of other pharmaceutically acceptable ingredients; 0-95 wt. % of one or more pharmaceutically acceptable excipients; the solid dosage unit comprising at least 5 μg of the partus control substance and having a pH buffer range of 3.5-5.7. The solid dosage unit of the present invention is easy to manufacture and perfectly suited for sublingual, buccal or sublabial administration. Furthermore, the dosage unit does not need to be stored and distributed under temperature controlled conditions.
-15. (canceled)
An orally disintegrating solid pharmaceutical dosage unit having a weight between 50 and 1,000 mg and comprising:
Dependencies are inferred from the claim text.